Nephros, Inc. (NEPH)
Nephros Market Cap : 29.80M for April 7, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Cerus Corp. | 350.71M |
| Abbott Laboratories | 176.97B |
| Accuray, Inc. | 44.64M |
| Alphatec Holdings, Inc. | 1.666B |
| Plus Therapeutics, Inc. | 19.90M |
Market Cap Related Metrics
| PE Ratio | 25.25 |
| PS Ratio | 1.621 |
| PEG Ratio | 0.0168 |
| Price to Book Value | 2.911 |
| Price to Free Cash Flow | 18.52 |
| Price | 2.80 |
| Earnings Yield | 3.96% |
| PEGY Ratio | 0.0168 |
| Operating PE Ratio | 26.58 |
| Normalized PE Ratio | 25.25 |